Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226486 | SCV000288848 | benign | Atrioventricular septal defect 5 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000380654 | SCV000337347 | benign | not specified | 2015-11-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001539615 | SCV001757407 | benign | not provided | 2019-04-22 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002463665 | SCV002605222 | uncertain significance | Neonatal insulin-dependent diabetes mellitus | criteria provided, single submitter | research | Potent mutations in GATA6 gene are associated with neonatal diabetes, decreased insulin production due to pancreatic aplasia or hypoplasia. Also associated with isolated cardiac abnormalities in children, like atrial septal defects.However no sufficient evidence is found to ascertain the role of this particular variant rs117646477 yet. | |
Ce |
RCV001539615 | SCV004137767 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | GATA6: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV001539615 | SCV005251244 | benign | not provided | criteria provided, single submitter | not provided |